Commitments and Contingencies (Details Narrative)				3 Months Ended
	Nov. 03, 2020	Dec. 13, 2019 USD ($) $ / shares shares	Dec. 13, 2019 EUR (€) shares	Mar. 31, 2022 USD ($)	Mar. 31, 2022 EUR (€)	Mar. 31, 2022 EUR (€)	Dec. 31, 2021 USD ($)
Initial Rent, In Month				$ 7,642
Right Of Use Assets In Exchange For Right Of Use Liabilities				461,341
Payable By Company For Services Rendered				9,588
Stock Option Expenses				803,207
Payments For Future Research And Collobration				767,678
Aggerate Amount Payable, Description	the Company to pay in aggregate of up to $2.9 million over a period of 22 months
Long Term Debt Payable				3,365,191
Grant Repyable				289,006
Operating Lease Right-of-use Assets				830,257			$ 383,551
Operating Lease Liabilities				843,443
Short Term Lease Costs				20,854
Finance Lease Obligations [Member]
Lease Payable				604,242
Operating Lease Right of Use Obligations [Member]
Operating Lease Liabilities				$ 881,024
Weighted Average Discount Rate				2.45%		2.45%
Weighted Average Remaining Lease Term				35 years	35 years
Payment Of Lease Liabilities				$ 55,975
Operating Lease Expense				72,865
Stock Incentive Plan [Member]
Stock Option Expenses				941,848
Restricted Stock				500,000
Total Of Stock Option				1,000,000
Managing Director's Agreement [Member]
Amount Payable				217
Royalty Payment				$ 134,217
Royality				6.00%	6.00%
Payable In Equal Monthly Installments | €						€ 288,000
Stock Based Compensation Expenses				$ 753,000
August 2021 [Member]
Compensation Expenses				805,840
Accrued Compensation				601,000
In 2018 [Member] | Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member]
Amount Repayable				$ 119,102
Terms Of Agreement Description				it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received	it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
Repayment Of Grants | €						181,500
Royality On Revenue				3.53%	3.53%
Grant Receivable | €						605,000
Grant Repaid By Installments				over 12 years	over 12 years
In 2018 [Member] | BNP Paribas leasing solutions [Member] | Finance Lease Obligations [Member]
Amount Payable				$ 0
Purchase Price For The Property | €						€ 25,000
Maturity Date				January 2022	January 2022
Implicit Interest				1.35%		1.35%
Leased Equipment Amortized Term				5 years	5 years
In 2018 [Member] | Clinical Study Research Agreement [Member] | University of Taiwan [Member]
Collaborative Obligations Amount Due				$ 510,000
Lease Agreement Expire Period				three-year	three-year
Collaborative Obligations Amount				$ 2,550,000
In 2010 [Member] | Walloon Region Government [Member]
Amount Repayable				$ 61,026
Terms Of Agreement Description				it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is equal to twice the amount of funding received	it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is equal to twice the amount of funding received
Repayment Of Grants | €						€ 314,406
Royality On Revenue				6.00%	6.00%
Grant Receivable | €						1,050,000.00
In 2020 [Member] | Walloon Region Government [Member]
Amount Repayable				$ 57,348
Terms Of Agreement Description				it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received	it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
Repayment Of Grants | €						148,500
Royality On Revenue				2.89%	2.89%
Grant Receivable | €						495,000
Grant Repaid By Installments				over 10 years	over 10 years
In 2020 [Member] | Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member]
Amount Repayable				$ 51,530
Terms Of Agreement Description				it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received	it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
Repayment Of Grants | €						278,830
Royality On Revenue				4.34%	4.34%
Grant Receivable | €						929,433
Grant Repaid By Installments				over 15 years	over 15 years
In 2016 [Member] | ING [Member] | Long-term Debt [Member]
Purchase Price For The Property | €						€ 1,120,000
Maturity Date				May 2031	May 2031
Fixed Interest Rate On Lease				2.62%		2.62%
Lease Payable				$ 533,346
In 2016 [Member] | Loan Agreement [Member] | ING [Member] | Long-term Debt [Member]
Maturity Date				December 2031	December 2031
Fixed Interest Rate				2.62%		2.62%
Repayment Of Long-term Loan Amount | €					€ 270,000
Principal Balance Payable				$ 209,267
Loan Agreement Term				15 years	15 years
In 2016 [Member] | Loan Agreement [Member] | Namur Invest [Member] | Long-term Debt [Member]
Maturity Date				December 2023	December 2023
Fixed Interest Rate				4.85%		4.85%
Repayment Of Long-term Loan Amount | €					€ 440,000
Loan Agreement Term				7 years	7 years
Total Long-term Debt				$ 146,891
In 2016 [Member] | Research Co-operation Agreement [Member] | DKFZ [Member]
Collaborative Obligations Amount Due				$ 221,913
Lease Agreement Expire Period				five-year	five-year
Collaborative Obligations Amount | €						€ 400,000
February 5, 2022 [Member] | Loan Agreement [Member] | First Insurance Funding [Member] | Long-term Debt [Member]
Maturity Date				November 2022	November 2022
Fixed Interest Rate				3.57%		3.57%
Repayment Of Long-term Loan Amount | €					€ 620,549
Loan Agreement Term				9 years	9 years
Total Long-term Debt				$ 551,599
Agreement Under Amount | €					€ 620,549
November 23, 2021 [Member] | Loan Agreement [Member] | SOFINEX [Member] | Long-term Debt [Member]
Maturity Date				June 2025	June 2025
Fixed Interest Rate				5.00%		5.00%
Repayment Of Long-term Loan Amount | €					€ 450,000
Loan Agreement Term				3 years 5 months 30 days	3 years 5 months 30 days
Total Long-term Debt				$ 499,304
Agreement Under Amount | €					€ 450,000
In 2017 [Member] | Loan Agreement [Member] | SOFINEX [Member] | Long-term Debt [Member]
Maturity Date				September 2024	September 2024
Fixed Interest Rate				4.50%		4.50%
Repayment Of Long-term Loan Amount | €					€ 1,000,000
Loan Agreement Term				7 years	7 years
Total Long-term Debt				$ 665,738
In 2018 [Member] | Loan Agreement [Member] | Namur Innovation and Growth [Member] | Long-term Debt [Member]
Maturity Date				June 2022	June 2022
Fixed Interest Rate				4.00%		4.00%
Repayment Of Long-term Loan Amount | €					€ 500,000
Loan Agreement Term				4 years	4 years
Total Long-term Debt				$ 42,250
In 2019 [Member] | Loan Agreement [Member] | Namur Invest [Member] | Long-term Debt [Member]
Maturity Date				September 2024	September 2024
Fixed Interest Rate				4.80%		4.80%
Repayment Of Long-term Loan Amount | €					€ 500,000
Loan Agreement Term				4 years	4 years
Total Long-term Debt				$ 405,646
October 13, 2020 [Member] | Loan Agreement [Member] | Namur [Member] | Long-term Debt [Member]
Maturity Date				March 2031	March 2031
Fixed Interest Rate				4.00%		4.00%
Repayment Of Long-term Loan Amount | €					€ 830,000
Loan Agreement Term				10 years	10 years
Total Long-term Debt				$ 844,496
On September 16, 2020 [Member] | Bioinformatic Analytics Of Cell Free DNA [Member]
Repayment Of Long-term Loan Amount | €					€ 54,879
Total Long-term Debt				16,771
Additional Cost Of Company | €					€ 155,115
In 2019 [Member] | Collaborative Arrangement, Co-promotion [Member]
Collaborative Obligations Amount Due				$ 18,994
Lease Agreement Expire Period				five-year	five-year
Collaborative Obligations Amount				$ 400,000
Research Collaboration Agreement Description				Company entered into a funded sponsored research agreement with the Texas A&M University (“TAMU”) in consideration for the license granted to the Company for a five-year period for a cost to the Company of up to $400,000 payable over such period	Company entered into a funded sponsored research agreement with the Texas A&M University (“TAMU”) in consideration for the license granted to the Company for a five-year period for a cost to the Company of up to $400,000 payable over such period
October 25, 2019 [Member] | TAMU [Member]
Non-controlling Interest				7.50%	7.50%
Equity Interest				12.50%	12.50%
Additional Interest				5.00%	5.00%
January 10, 2020 [Member]
Agrrement Liability		$ 6,535
Common Stock, Restricted Shares Issued In Exchange Of Purchased Outstanding Shares, Value		$ 333,969
Restricted Shares Issued | shares		73,263	73,263
Common Stock, Restricted Shares Issued In Exchange Of Purchased Outstanding Shares, Shares | shares		73,263	73,263
Weighted Trading Price Per Share | $ / shares		$ 4.56
Repayment Of Debt | €			€ 350,000
Common Stock Adjusted Amount		$ 357,000
Holdback Period				9 years	9 years
Holdback Liabilities				$ 55,404
Net Liabilities		$ 43,152